Try our beta test site

A Study of LY3023414 in Participants With Advanced Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2017 by Eli Lilly and Company
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT01655225
First received: July 19, 2012
Last updated: March 20, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 4, 2018
  Estimated Primary Completion Date: March 4, 2018 (Final data collection date for primary outcome measure)